Pfizer, a US-based drug company, is said to dismiss its merger deal with Allergan. The US drugmaker wants to quit from the $160 billion merger deal since Washington authorities set new rules, making corporate inversions harder.
Allergen
Breaking News
- Taylor Swift Reaches Her Billionaire' Era,' Joining Elon Musk and Jeff Bezos on the List of World's Wealthiest People
- Biden Administration to Provide $1.5 Billion Loan to Reopen Michigan Nuclear Power Plant, a First in the US
- Four Deaths May Be Linked to Dietary Supplements Made by Japan’s Kobayashi Pharmaceutical: Report
Pfizer today confirmed that the company has increased the price of some of its drugs although it was not revealed how many drugs are involved with the price hike. According to a data by Wolters Kluwer which revealed that more than 100 types of drugs has been increased in its price starting on January 1st.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- Citigroup to Complete Sweeping Overhaul This Week After Laying Off 5,000 Employees
- Disney, Florida Gov. Ron DeSantis' Allies Settle Lawsuit Over Disney World Special District, Ending Feud Over 'Don't Say Gay' Law
- North Korea Refuses Peace Talk With Japan Unless They Confront Their 'Brutal' History; Business Relations at Risk